GEOVAX LABS, INC. Current Assets
GEOVAX LABS, INC. (GOVX) had Current Assets of $4.18 million as of 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-09-17
- 2026-06-30: Assets, Current $4.18M.
- 2026-03-31: Assets, Current $2.43M.
- 2025-12-31: Assets, Current $5.31M.
- 2025-09-30: Assets, Current $6.52M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $4.18M S-1 · filed 2026-09-17 |
| 2026-03-31 | $2.43M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $5.31M S-1 · filed 2026-09-17 |
| 2025-09-30 | $6.52M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.14M 10-Q · filed 2025-07-28 |
| 2025-03-31 | $10.61M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $7.93M S-1 · filed 2026-09-17 |
| 2024-09-30 | $10.87M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.84M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $2.86M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $7.89M 10-K · filed 2025-03-27 |
| 2023-09-30 | $14.80M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $19.83M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $25.99M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $28.94M 10-K · filed 2024-02-29 |
| 2022-09-30 | $36.14M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $32.04M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $16.64M 10-Q · filed 2022-04-27 |
| 2021-12-31 | $11.63M 10-K · filed 2023-03-23 |
| 2021-09-30 | $18.16M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $19.66M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $20.96M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $10.24M 10-K · filed 2022-03-09 |
| 2020-09-30 | $11.73M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $938.32K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $810.21K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $447.26K 10-K · filed 2021-03-23 |
| 2019-09-30 | $795.59K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $319.80K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $447.91K 10-Q · filed 2019-05-13 |
| 2018-12-31 | $619.70K 10-K · filed 2020-03-24 |
| 2018-09-30 | $596.19K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $339.15K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $802.32K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $448.07K 10-K · filed 2019-03-26 |
| 2017-09-30 | $446.14K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $933.62K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $240.39K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $544.38K 10-K · filed 2018-03-23 |
| 2016-09-30 | $602.16K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $258.82K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $709.03K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $1.24M 10-K · filed 2017-03-24 |
| 2015-09-30 | $1.90M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $2.55M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $3.24M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $1.23M 10-K · filed 2016-03-16 |
| 2014-09-30 | $926.39K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $1.40M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $2.05M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $2.70M 10-K · filed 2015-03-20 |
| 2013-09-30 | $1.79M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $1.95M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $2.01M 10-Q · filed 2013-05-01 |
| 2012-12-31 | $1.34M 10-K · filed 2014-03-14 |
| 2012-09-30 | $1.88M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $2.11M 10-Q · filed 2012-08-13 |
| 2012-03-31 | $2.63M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $1.42M 10-K · filed 2013-03-18 |
| 2011-09-30 | $1.00M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $1.35M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $1.60M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |